Cargando…
A Systematic Inflammation-based Model in Advanced Pancreatic Ductal Adenocarcinoma
Emerging evidence revealed the critical role of systematic inflammation in pancreatic ductal adenocarcinoma (PDAC). In the present study, we reviewed the records of 279 patients with advanced PDAC. Among them, 147 cases were used as the training cohort and another 132 as the validation cohort. In th...
Autores principales: | Wu, Li-Xia, Wang, Xiao-Yong, Xu, Ke-Qun, Lin, Yu-Li, Zhu, Wen-Yu, Han, Long, Shao, Yue-Ting, Zhou, Han-Yu, Jiang, Hua, Hang, Jun-Jie, Yang, Xu-Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856880/ https://www.ncbi.nlm.nih.gov/pubmed/31777596 http://dx.doi.org/10.7150/jca.30561 |
Ejemplares similares
-
Advances on diagnostic biomarkers of pancreatic ductal adenocarcinoma: A systems biology perspective
por: Zhang, Wu-Hu, et al.
Publicado: (2020) -
Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects
por: Li, Ke-Yu, et al.
Publicado: (2020) -
Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma
por: Yang, Xiao-Yan, et al.
Publicado: (2023) -
Advances in Pancreatic Ductal Adenocarcinoma Treatment
por: Anderson, Eric M., et al.
Publicado: (2021) -
Advances in the management of pancreatic ductal adenocarcinoma
por: O’Kane, Grainne M., et al.
Publicado: (2021)